These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33801580)

  • 1. Crk and CrkL as Therapeutic Targets for Cancer Treatment.
    Park T
    Cells; 2021 Mar; 10(4):. PubMed ID: 33801580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity.
    Park T; Large N; Curran T
    J Biol Chem; 2021; 296():100390. PubMed ID: 33561443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast Growth Requires CT10 Regulator of Kinase (Crk) and Crk-like (CrkL).
    Park T; Koptyra M; Curran T
    J Biol Chem; 2016 Dec; 291(51):26273-26290. PubMed ID: 27807028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel role for CRK adaptor proteins as essential components of SRC/FAK signaling for epithelial-mesenchymal transition and colorectal cancer aggressiveness.
    Franke FC; Slusarenko BO; Engleitner T; Johannes W; Laschinger M; Rad R; Nitsche U; Janssen KP
    Int J Cancer; 2020 Sep; 147(6):1715-1731. PubMed ID: 32147820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crk and CrkL present with different expression and significance in epithelial ovarian carcinoma.
    Wang J; Che YL; Li G; Liu B; Shen TM; Wang H; Linghu H
    Mol Carcinog; 2011 Jul; 50(7):506-15. PubMed ID: 21319228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential roles of Crk and CrkL in fibroblast structure and motility.
    Park TJ; Curran T
    Oncogene; 2014 Oct; 33(43):5121-32. PubMed ID: 24166500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.
    Fathers KE; Bell ES; Rajadurai CV; Cory S; Zhao H; Mourskaia A; Zuo D; Madore J; Monast A; Mes-Masson AM; Grosset AA; Gaboury L; Hallet M; Siegel P; Park M
    Breast Cancer Res; 2012 May; 14(3):R74. PubMed ID: 22569336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
    Franke FC; Müller J; Abal M; Medina ED; Nitsche U; Weidmann H; Chardonnet S; Ninio E; Janssen KP
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):33-53. PubMed ID: 30480076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement for Crk and CrkL during postnatal lens development.
    Park T; Curran T
    Biochem Biophys Res Commun; 2020 Aug; 529(3):603-607. PubMed ID: 32736680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crk and CrkL are required for cell transformation by v-fos and v-ras.
    Koptyra M; Park TJ; Curran T
    Mol Carcinog; 2016 Jan; 55(1):97-104. PubMed ID: 25557916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of phosphotyrosine-containing peptides to target SH2 domains: Antagonist peptides of the Crk/CrkL-p130Cas axis.
    Douglas JT; Johnson DK; Roy A; Park T
    Methods Enzymol; 2024; 698():301-342. PubMed ID: 38886037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition.
    Guo C; Zhao D; Zhang Q; Liu S; Sun MZ
    Sci Rep; 2018 Feb; 8(1):2375. PubMed ID: 29403024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crk-like adapter protein regulates CCL19/CCR7-mediated epithelial-to-mesenchymal transition via ERK signaling pathway in epithelial ovarian carcinomas.
    Cheng S; Guo J; Yang Q; Yang X
    Med Oncol; 2015 Mar; 32(3):47. PubMed ID: 25636509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential role of the
    Imamoto A; Ki S; Li L; Iwamoto K; Maruthamuthu V; Devany J; Lu O; Kanazawa T; Zhang S; Yamada T; Hirayama A; Fukuda S; Suzuki Y; Okada M
    Life Sci Alliance; 2020 Feb; 3(2):. PubMed ID: 32041892
    [No Abstract]   [Full Text] [Related]  

  • 15. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
    Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
    BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crk and Crk-like play essential overlapping roles downstream of disabled-1 in the Reelin pathway.
    Park TJ; Curran T
    J Neurosci; 2008 Dec; 28(50):13551-62. PubMed ID: 19074029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
    Uemura N; Salgia R; Li JL; Pisick E; Sattler M; Griffin JD
    Leukemia; 1997 Mar; 11(3):376-85. PubMed ID: 9067577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avian and 1918 Spanish influenza a virus NS1 proteins bind to Crk/CrkL Src homology 3 domains to activate host cell signaling.
    Heikkinen LS; Kazlauskas A; Melén K; Wagner R; Ziegler T; Julkunen I; Saksela K
    J Biol Chem; 2008 Feb; 283(9):5719-27. PubMed ID: 18165234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptor proteins CRK and CRKL associate with the serine/threonine protein kinase GCKR promoting GCKR and SAPK activation.
    Shi CS; Tuscano J; Kehrl JH
    Blood; 2000 Feb; 95(3):776-82. PubMed ID: 10648385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
    Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
    Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.